Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Alitretinoin Gel in AIDS-Related Kaposi's Sarcoma
NCT00002439Phase 3Completed
- Sponsor
- Anderson Clinical Research
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial in Kaposi sarcoma (KS) comparing Alitretinoin Gel with Vehicle Gel (2 arms). Primary endpoint: Cutaneous Kaposi's Sarcoma Tumor Response Rate at 12 weeks. Status: completed.
02
Drugs
alitretinoin
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT00002439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002439.